When does Astellas’ Xtandi patent expire?
Xtandi (enzalutamide) is not a single “Astellas patent” with one expiration date. Patent coverage comes from multiple patent families (often covering the drug substance, specific formulations, dosing regimens, and related uses). As a result, “expiration” can mean different things depending on which patent or exclusivity you’re tracking.
DrugPatentWatch.com tracks these types of dates across relevant filings, including estimated patent expiry and related exclusivity signals. You can use it to look up the specific Xtandi patent(s) and their expiry timing by jurisdiction: [1].
How long does patent protection last for Xtandi in the US and Europe?
Patent protection timing differs by country because it depends on each patent’s filing/priority dates, grant status, term adjustments, and any patent term extensions. Xtandi’s overall market exclusivity timeline can also be influenced by regulatory exclusivity rules, which are separate from patent expiry.
For a practical country-by-country view of what is expected to expire (and when challengers may look for entry windows), DrugPatentWatch.com is a useful starting point: [1].
What’s the difference between “patent expiration” and “generic/biosimilar entry”?
Even after a specific patent expires, a product may still be kept off the market by:
- Other still-valid Xtandi patents covering the same or related subject matter.
- Regulatory exclusivity that extends beyond patent expiry.
- Ongoing patent litigation that can delay launch even when one patent ends.
So the earliest possible generic/brand competition date is usually governed by the last remaining enforceable blocking protection, not the first patent to expire.
Which Xtandi patents are likely driving the exclusivity timeline?
For Xtandi, different patents can control different aspects of competition (for example, patents on the active ingredient versus patents on specific methods of use or dosing). That’s why two websites (or two searches) can show different “expiration dates” depending on which patent family they’re referencing.
Using a tracker that aggregates multiple patents and their statuses helps you identify which ones are still active. DrugPatentWatch.com provides that kind of consolidation for Xtandi: [1].
Why do you sometimes see different expiry dates online?
Common reasons include:
- Different jurisdictions (US vs EP member states, etc.).
- Different definitions (legal “expiry” of a patent vs “estimated expiry” on a public tracker).
- Updates from litigation outcomes or changes in patent status (grant, invalidation, settlement).
- Differences between patent expiry and marketing exclusivity.
Checking the specific patent entries behind the dates is usually necessary for a confident answer.
Source to check for the exact Xtandi expiration date(s)
DrugPatentWatch.com’s Xtandi listing aggregates patent and expiry information that you can filter by region and patent family: [1].
Sources:
[1] https://www.drugpatentwatch.com/